ChronoScale (CHRN) Common Equity (2012 - 2026)

ChronoScale (CHRN) has 15 years of Common Equity data on file, last reported at $2.1 million in Q1 2026.

• Common Equity for Q1 2026 came in at $2.1 million, down 83.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (down 83.53% YoY), and the FY2025 annual result was $9.0 million, down 28.96% from the prior year.
• Common Equity slipped to $2.1 million in Q1 2026 per CHRN's latest filing, from $9.0 million in the prior quarter.
• Over five years, Common Equity peaked at $33.5 million in Q1 2022 and troughed at $2.1 million in Q1 2026.
• A 5-year average of $16.7 million and a median of $14.1 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2024 and 2026: Common Equity gained 0.8% in 2024, then sank 83.53% in 2026.
• A 5-year view of Common Equity shows it stood at $25.4 million in 2022, then slumped by 50.45% to $12.6 million in 2023, then advanced by 0.8% to $12.7 million in 2024, then declined by 28.96% to $9.0 million in 2025, then sank by 76.85% to $2.1 million in 2026.
• Business Quant data shows CHRN's Common Equity at $2.1 million in Q1 2026, $9.0 million in Q4 2025, and $9.7 million in Q3 2025.